Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–50 of 125 pages matching "2026"

MDS 2026 — Fluid Biomarker Advances in NeurodegenerationKG

event · 3,615 words · 278 hyp40 ana97 exp

MDS 2026 — Fluid Biomarker Advances in NeurodegenerationKG

event · 3,615 words · 278 hyp39 ana97 exp

AAIC 2026: Combination Therapy and Multi-Target Approaches in Alzheimer's DiseaseKG

event · 2,892 words · 63 hyp34 ana48 exp

📊 adpd-2026-seed-amplification-assaysKG

biomarker · 2,853 words · 14 hyp7 ana2 exp

adpd-2026-seed-amplification-assaysKG

general · 2,853 words · 5 hyp5 ana

📊 adpd-2026-precision-medicine-genetic-stratificationKG

biomarker · 2,612 words · 37 hyp11 ana14 exp

adpd-2026-precision-medicine-genetic-stratificationKG

general · 2,612 words · 14 hyp5 ana5 exp

MDS 2026: Neuroprotection and Neurorestorative Strategies for Parkinson's DiseaseKG

conference · 2,523 words · 18 hyp19 ana106 exp

AAIC 2026: Tau ImmunotherapyKG

event · 2,414 words · 10 hyp4 ana1 exp

AAIC 2026: Synaptic Dysfunction and Neural Circuit AlterationsKG

event · 2,393 words · 11 hyp13 ana2 exp

mds-2026-advanced-neuroimagingKG

general · 2,376 words · 4 hyp23 ana32 exp

AAN 2026 — Deep Brain Stimulation and Neurotechnology AdvancesKG

event · 2,310 words · 5 hyp19 ana

AAIC 2026: Poster and Abstract HighlightsKG

event · 2,079 words · 18 hyp3 ana2 exp

mds-2026-gba-lrrk2-genetic-susceptibilityKG

general · 2,022 words · 3 hyp17 ana33 exp

AAIC 2026 — Neurovascular Function and Cerebral Blood Flow in Alzheimer'sKG

general · 1,999 words · 14 hyp8 ana2 exp

📊 aaic-2026-blood-biomarkersKG

biomarker · 1,949 words · 8 hyp10 ana4 exp

📊 AD/PD 2026 Blood BiomarkersKG

biomarker · 1,922 words · 13 hyp10 ana4 exp

AAIC 2026: Clinical Trial UpdatesKG

event · 1,919 words · 15 hyp2 ana

💊 Levodopa-Induced Dyskinesia Management — MDS 2026KG

therapeutic · 1,882 words · 4 hyp8 ana5 exp

AD/PD 2026 ConferenceKG

event · 1,834 words · 9 hyp4 ana1 exp

AAIC 2026: Satellite Symposia and SponsorsKG

event · 1,776 words · 17 hyp1 ana

⚙️ Synaptic Dysfunction in Neurodegeneration - SfN 2026 ResearchKG

mechanism · 1,715 words · 293 hyp58 ana58 exp

MDS 2026 — Huntington's Disease SessionsKG

event · 1,704 words · 4 hyp14 ana31 exp

therapeutic-antibodiesKG

general · 1,686 words · 17 hyp20 ana1 exp

CTAD 2026 — Clinical Trials on Alzheimer's DiseaseKG

event · 1,657 words · 32 hyp17 ana71 exp

ctad-2026-tau-immunotherapyKG

general · 1,614 words · 1 hyp1 ana7 exp

AAIC 2026: Nutrition, Lifestyle, and Prevention StrategiesKG

event · 1,601 words · 14 hyp6 ana

AAIC 2026 Company PresentationsKG

event · 1,548 words · 15 hyp4 ana

mds-2026-prodromal-early-onset-parkinson-biomarkersKG

general · 1,540 words · 3 hyp9 ana33 exp

immunotherapy-updateKG

general · 1,500 words · 50 hyp37 ana7 exp

MDS 2026 — Precision Medicine in Parkinson's DiseaseKG

event · 1,497 words · 9 hyp21 ana90 exp

propagation-seeding-biomarkersKG

general · 1,484 words · 8 hyp8 ana2 exp

⚙️ Emerging Therapeutic Directions 2025-2026KG

mechanism · 1,468 words · 14 hyp49 ana13 exp

MDS 2026 — Alpha-Synuclein & Lewy Body ResearchKG

event · 1,454 words · 2 hyp2 ana31 exp

AAIC 2026 Plenary SessionsKG

event · 1,451 words · 14 hyp5 ana

Dysautonomia and Non-Motor Complications in PD — MDS 2026KG

event · 1,431 words · 4 hyp2 ana1 exp

AAIC 2026: Epigenetic and Genetic Biomarkers in Alzheimer'sKG

event · 1,426 words · 22 hyp10 ana3 exp

⚙️ MDS 2026 — PD Genetic and Molecular MechanismsKG

mechanism · 1,422 words · 18 hyp36 ana35 exp

mds-2026-parkinsons-sleep-circadianKG

general · 1,418 words · 11 hyp12 ana31 exp

MDS 2026 — Freezing of Gait and Postural Instability in Parkinson's DiseaseKG

event · 1,413 words · 3 hyp14 ana90 exp

AAIC 2026: Cognitive Reserve and Lifestyle InterventionsKG

event · 1,410 words · 12 hyp4 ana1 exp

AAIC 2026: Amyloid and Tau Imaging AdvancesKG

event · 1,321 words · 4 hyp7 ana13 exp

📊 AAIC 2026: Tau-PET Imaging and Fluid Biomarker IntegrationKG

biomarker · 1,317 words · 7 hyp4 ana16 exp

MDS 2026 — Tremor and Hyperkinetic Movement DisordersKG

event · 1,292 words · 3 hyp3 ana33 exp

MDS 2026KG

event · 1,274 words · 3 hyp20 ana31 exp

aaic-2026-tau-imaging-biomarker-validationKG

general · 1,209 words · 1 hyp2 ana15 exp

CTAD 2026: Amyloid-Targeting Antibody Trial ResultsKG

event · 1,187 words · 19 hyp16 ana13 exp

MDS 2026 — Motor Complications in Parkinson's DiseaseKG

event · 1,178 words · 1 hyp14 ana90 exp

MDS 2026 — Genetics and Biomarkers in Movement DisordersKG

page · 1,173 words · 6 hyp7 ana36 exp

MDS 2026: Surgical Therapies for Parkinson's DiseaseKG

event · 1,107 words · 2 hyp14 ana90 exp